bendroflumethiazide has been researched along with Heart Failure in 21 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of slow-release furosemide and bendroflumethiazide in the ambulatory treatment of mild to moderate congestive heart failure were compared in a controlled multicentre study using a randomized, double-blind procedure." | 9.05 | Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure. ( Pehrsson, SK, 1985) |
| "The additive natriuretic and diuretic effects of theophylline ethylenediamine and of bendroflumethiazide have been compared in permutation trial tests in patients with advanced congestive heart failure receiving long-term treatment with the highly potent diuretic, bumetanide." | 9.04 | Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment with the potent diuretic bumetanide. Permutation trial tests in patients with congestive heart failure. ( Olesen, KH; Sigurd, B, 1978) |
| "Bendrofluazide and metolazone were equally effective in establishing a diuresis in patients with severe congestive cardiac failure resistant to loop diuretics." | 5.07 | Combination diuretic treatment in severe heart failure: a randomised controlled trial. ( Channer, KS; Lawson-Matthew, P; McLean, KA; Richardson, M, 1994) |
| "Eight patients with mild heart failure were treated in random order for 1 week with 2 mg bumethanide at 0800 and 1200 (treatment 1) h, 1 mg bumethanide at 0800, 1200, 1800, 2200 (treatment 2) and 5 mg bendroflumethiazide at 0800 and 1800 (treatment 3) h." | 5.07 | A comparison of three diuretic regimens in heart failure. ( Andreasen, F; Bech, OM; Bruun, P; Diamant, B; Eriksen, UH; Guul, SJ; Hartling, OJ; Hvidt, S; Kahr, O; Nielsen, LP, 1993) |
| "The effects of slow-release furosemide and bendroflumethiazide in the ambulatory treatment of mild to moderate congestive heart failure were compared in a controlled multicentre study using a randomized, double-blind procedure." | 5.05 | Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure. ( Pehrsson, SK, 1985) |
| "The additive natriuretic and diuretic effects of theophylline ethylenediamine and of bendroflumethiazide have been compared in permutation trial tests in patients with advanced congestive heart failure receiving long-term treatment with the highly potent diuretic, bumetanide." | 5.04 | Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment with the potent diuretic bumetanide. Permutation trial tests in patients with congestive heart failure. ( Olesen, KH; Sigurd, B, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (80.95) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CACCAMO, LP | 1 |
| BRETTELL, HR | 1 |
| SMITH, JG | 1 |
| AIKAWA, JK | 1 |
| CUMMINGS, DE | 1 |
| GOODMAN, RM | 1 |
| STEIGMANN, F | 1 |
| JOHNSTON, LC | 1 |
| GRIEBLE, HG | 1 |
| SCHOENBERGER, JA | 1 |
| FULLER, JB | 1 |
| Gabriel, R | 1 |
| Baylor, P | 1 |
| Channer, KS | 2 |
| McLean, KA | 1 |
| Lawson-Matthew, P | 1 |
| Richardson, M | 2 |
| Andreasen, F | 1 |
| Eriksen, UH | 1 |
| Guul, SJ | 1 |
| Nielsen, LP | 1 |
| Bech, OM | 1 |
| Diamant, B | 1 |
| Kahr, O | 1 |
| Bruun, P | 1 |
| Hartling, OJ | 1 |
| Hvidt, S | 1 |
| Uusimaa, P | 1 |
| Tokola, H | 1 |
| Ruskoaho, H | 1 |
| Vuolteenaho, O | 1 |
| Risteli, J | 1 |
| Ylitalo, A | 1 |
| Peuhkurinen, K | 1 |
| Sigurd, B | 3 |
| Olesen, KH | 3 |
| Lawson, DH | 1 |
| Boddy, K | 1 |
| Gray, JM | 1 |
| Mahaffey, M | 1 |
| Mills, E | 1 |
| Wennevold, A | 1 |
| Crook, R | 1 |
| Jones, JV | 1 |
| Bain, PG | 1 |
| Egner, W | 1 |
| Walker, PR | 1 |
| Pehrsson, SK | 1 |
| Dyckner, T | 1 |
| Wester, PO | 1 |
| Juul, J | 2 |
| Somers, K | 1 |
| Sood, NK | 1 |
| Brenton, DP | 1 |
| Nielsen, U | 1 |
| Stewart, JH | 1 |
| Edwards, KD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Tolerability of Combination Intravenous Diuretic Therapy Versus Intravenous Loop Diuretic Therapy Alone for the Treatment of Acute Decompensated Heart Failure[NCT05840536] | Phase 4 | 0 participants (Actual) | Interventional | 2014-05-31 | Withdrawn | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 trials available for bendroflumethiazide and Heart Failure
| Article | Year |
|---|---|
Comparison of the chronic effects of bendrofluazide, bumetanide and frusemide on plasma biochemical variables.
Topics: Aged; Analysis of Variance; Bendroflumethiazide; Blood Chemical Analysis; Bumetanide; Clinical Trial | 1981 |
Combination diuretic treatment in severe heart failure: a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bendroflumethiazide; Body Weight; Creatinine; Diuretics; | 1994 |
A comparison of three diuretic regimens in heart failure.
Topics: Aged; Aged, 80 and over; Bendroflumethiazide; Blood Volume; Bumetanide; Circadian Rhythm; Diuretics; | 1993 |
Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment with the potent diuretic bumetanide. Permutation trial tests in patients with congestive heart failure.
Topics: Bendroflumethiazide; Bumetanide; Clinical Trials as Topic; Diuresis; Diuretics; Drug Evaluation; Dru | 1978 |
The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
Topics: Adult; Bendroflumethiazide; Benzoates; Butylamines; Chlorides; Clinical Trials as Topic; Coronary Di | 1975 |
Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure.
Topics: Adult; Aged; Bendroflumethiazide; Clinical Trials as Topic; Delayed-Action Preparations; Female; Fur | 1985 |
[Amiloride. A clinical study of a potassium-retaining diuretic].
Topics: Adult; Aged; Bendroflumethiazide; Bicarbonates; Clinical Trials as Topic; Diuresis; Diuretics; Femal | 1969 |
The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
Topics: Adult; Bendroflumethiazide; Clinical Trials as Topic; Diuresis; Drug Synergism; Furosemide; Heart Fa | 1971 |
Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid.
Topics: Adult; Aged; Bendroflumethiazide; Diuretics; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failu | 1965 |
12 other studies available for bendroflumethiazide and Heart Failure
| Article | Year |
|---|---|
Benzydroflumethiazide in the treatment of edematous states: a preliminary trial.
Topics: Bendroflumethiazide; Edema; Heart Failure; Humans; Steroids | 1962 |
S35-LABELED BENDROFLUMETHIAZIDE IN HUMAN BEINGS: CLINICAL STUDIES.
Topics: Adolescent; Bendroflumethiazide; Chlorothiazide; Geriatrics; Heart Failure; Humans; Hydrochlorothiaz | 1964 |
BENDROFLUMETHIAZIDE IN THE TREATMENT OF CARDIAC EDEMA AND HYPERTENSION.
Topics: Ascorbic Acid; Bendroflumethiazide; Diuretics; Edema, Cardiac; Electrolytes; Feeding and Eating Diso | 1964 |
TREATMENT OF ARTERIAL HYPERTENSIVE DISEASE WITH DIURETICS. III. CHLORTHALIDONE ALONE AND IN COMBINATION WITH SPIRONOLACTONE.
Topics: Bendroflumethiazide; Cardiomegaly; Chlorides; Chlorthalidone; Coronary Disease; Creatine; Creatinine | 1964 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardi | 2001 |
Potassium supplements in patients receiving long-term diuretics for oedema.
Topics: Bendroflumethiazide; Body Composition; Bumetanide; Diuretics; Edema, Cardiac; Female; Furosemide; He | 1976 |
Thiazides with loop diuretics for severe congestive heart failure.
Topics: Aged; Bendroflumethiazide; Diuresis; Drug Administration Schedule; Drug Therapy, Combination; Female | 1990 |
Thiazide-induced dilutional hyponatraemia masquerading as subarachnoid haemorrhage.
Topics: Aged; Amiloride; Bendroflumethiazide; Diagnosis, Differential; Drug Combinations; Female; Heart Fail | 1986 |
Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure.
Topics: Aged; Bendroflumethiazide; Diuretics; Electrolytes; Extracellular Space; Female; Furosemide; Heart F | 1985 |
Therapeutic conferences. Heart failure--I.
Topics: Aged; Bendroflumethiazide; Diet; Digoxin; Diuretics; Female; Furosemide; Heart; Heart Failure; Human | 1971 |
A clinical evaluation of debrisoquine sulphate.
Topics: Adult; Aged; Amidines; Antihypertensive Agents; Bendroflumethiazide; Digitalis Glycosides; Female; H | 1968 |
[MK 870. A comparison of the saluretic action of MK 870, bendroflumethiazide and bendroflumethiazide + MK 870].
Topics: Adult; Aged; Bendroflumethiazide; Chlorides; Diuretics; Electrolytes; Female; Heart Failure; Humans; | 1968 |